Cartalax (20mg) is a synthetic peptide bioregulator commonly studied in laboratory research focused on connective tissue signaling and cartilage-specific regulatory pathways. Cartalax belongs to a class of short peptide sequences originally identified for their role in organ- and tissue-specific cellular communication, particularly within cartilage and joint tissue models. This peptide is formulated for laboratory research examining chondrocyte regulation, extracellular matrix signaling, and tissue maintenance mechanisms.
Prior to the development and synthesis of targeted bioregulatory peptides, research into cartilage and connective tissue regulation relied largely on broad molecular signaling agents and nonspecific interventions. In controlled research settings, Cartalax has been studied for its potential role in influencing gene expression, cellular differentiation, and regenerative signaling within cartilage tissue. Its tissue-specific research focus allows investigators to explore localized regulatory pathways involved in cartilage structure and function models.
Currently, Cartalax is being investigated for potential applications in cartilage research models, connective tissue signaling studies, joint tissue regulation research, and age-associated cellular regulation pathways. Additional investigation continues into its role in maintaining cellular homeostasis, adaptive response mechanisms, and organ-specific regulatory signaling within connective tissue systems. Due to its targeted research profile, Cartalax remains a compelling subject for ongoing laboratory investigation.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Cartalax (20mg) is a synthetic peptide compound studied in laboratory environments for its interaction with cartilage tissue signaling pathways and connective tissue regulatory mechanisms. In experimental models, Cartalax has been investigated for its potential involvement in cellular communication processes related to chondrocyte function, cartilage maintenance, and extracellular matrix regulation. This formulation is supplied strictly for controlled laboratory research applications focused on musculoskeletal tissue signaling and cartilage biology.
Cartilage tissue plays a crucial structural role within joints, providing both mechanical support and shock absorption. Researchers studying musculoskeletal biology often investigate compounds capable of influencing chondrocyte signaling pathways, extracellular matrix dynamics, and cellular repair mechanisms associated with cartilage tissue. Cartalax has therefore become a compound of interest within experimental programs examining cartilage physiology and connective tissue regulation.
Cartalax (20mg) – Research Specifications:
| Compound | Cartalax |
| Quantity | 20mg per vial |
| Compound Type | Synthetic peptide studied for cartilage and connective tissue signaling |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific analytical verification |
| Appearance | Lyophilized peptide powder |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human consumption or clinical use. |
Cartalax is part of a class of short regulatory peptides studied in laboratory environments examining cartilage tissue biology and connective tissue signaling pathways. In experimental musculoskeletal research models, peptides like Cartalax are evaluated for their potential influence on cellular communication networks involved in cartilage maintenance and extracellular matrix regulation.
Cartilage is composed of specialized cells known as chondrocytes that regulate the production and maintenance of the extracellular matrix. This matrix provides structural support and resilience to mechanical stress. Researchers studying joint physiology frequently investigate compounds capable of influencing chondrocyte activity and extracellular matrix signaling pathways in controlled laboratory environments.
Musculoskeletal research programs often examine multiple tissue repair pathways simultaneously, including inflammatory signaling, collagen regulation, and connective tissue maintenance processes. For example, experimental studies examining tissue repair signaling may also reference compounds such as BPC 157, Thymosin Beta 4, and GHK-CU, which are frequently studied in broader laboratory research models examining connective tissue repair and cellular signaling pathways.
Important Research Notice: Nordsci research materials are supported by lot-specific analytical documentation. Certificates of Analysis are available for laboratories requiring verification of compound identity and analytical quality standards.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
Cartilage biology studies often focus on the cellular signaling pathways that regulate chondrocyte function and extracellular matrix production. Researchers may investigate Cartalax in experimental models examining how peptide signaling influences cartilage tissue stability and cellular communication.
Connective tissues rely on coordinated signaling between cellular and structural components to maintain mechanical integrity. Laboratory research programs may explore how peptide compounds interact with pathways associated with collagen regulation and connective tissue maintenance.
Joint tissues experience constant mechanical stress during movement and physical activity. Researchers studying joint physiology may examine compounds involved in maintaining structural resilience and cellular repair mechanisms within cartilage and connective tissue environments.
The extracellular matrix plays a critical role in maintaining tissue architecture and cellular communication. Experimental models may investigate how peptide signaling compounds influence extracellular matrix pathways involved in structural regulation and tissue maintenance.
Cartalax (20mg) should be handled using standard laboratory protocols established for peptide research materials. Proper storage conditions, environmental controls, and documentation of experimental parameters help ensure reliable outcomes in musculoskeletal research programs.
Protocol Design Considerations: Cartilage research experiments may be influenced by variables including mechanical stress conditions, inflammatory signaling levels, extracellular matrix composition, and cellular metabolic activity. Researchers should maintain strict experimental controls when designing studies involving peptide signaling compounds.
Note: The information above is provided strictly for laboratory research reference purposes. All experiments should be conducted by qualified personnel within appropriate laboratory facilities.
Each lot of Cartalax supplied by Nordsci Peptides includes a Certificate of Analysis confirming compound identity and analytical purity verification. These reports support laboratory documentation standards and traceability requirements within controlled research programs.
Laboratories sourcing peptide materials typically prioritize analytical transparency, manufacturing consistency, and batch traceability. Nordsci Peptides supplies research-grade peptide compounds supported by analytical verification and documentation designed to support reliable laboratory research workflows.
IMPORTANT: Cartalax (20mg) is supplied exclusively for laboratory research use. It is not approved for human consumption or therapeutic use. Researchers are responsible for ensuring compliance with all applicable institutional and regulatory guidelines governing research materials.
